Clinical Trials Browser

Phase 2 × Urogenital Diseases × Genitourinary × Clear all

NCT07457164 2026-03-12

A Study Investigating the Pharmacokinetics, Pharmacodynamics, Efficacy and Safety of Teverelix DP, a Gonadotropin-releasing Hormone (GnRH) Antagonist, in Patients With Advanced Prostate Cancer

Phase 2 Not yet recruiting

Urogenital Diseases, Prostatic Diseases

NCT03081884 2021-01-25

EDRN-FACBC

Phase 2 Completed

61 enrolled 6 charts

Urogenital Diseases, Neoplasm Metastasis, Neoplasms, Prostatic Neoplasms

NCT02830880 2020-01-07

FACBC Prostate Therapy Response

Phase 2 Completed

7 enrolled 10 charts

Urogenital Diseases, Neoplasms, Prostatic Neoplasms